STAT+: Pharmalittle: We’re reading about an FDA commissioner candidate, Germany’s plans for drug prices, and more
Regenxbio plans to apply for accelerated approval for its gene therapy for Duchenne muscular dystrophy.
All sources
- STAT News · Center
Prism News is a free news aggregator that breaks every story into Left, Center and Right perspectives — see what each side covers, what they ignore, and how the same event gets framed differently.